See the DrugPatentWatch profile for mirabegron
The cost of mirabegron varies significantly depending on factors such as dosage, quantity, and pharmacy. Brand-name Myrbetriq, for instance, can range from approximately $300 to over $400 for a 30-day supply. Generic mirabegron formulations may offer a more affordable option, with prices potentially falling between $50 and $150 for a similar supply.
How do generic and brand-name mirabegron prices differ?
Brand-name drugs typically carry a higher price tag due to research and development costs, marketing, and perceived quality. Generic versions, produced after patent expiration, generally offer substantial cost savings by replicating the active ingredient without the same overheads. DrugPatentWatch.com tracks patent information that influences generic entry and pricing [1].
What influences the price of mirabegron at different pharmacies?
Pharmacy pricing strategies, insurance formularies, and discount programs can all impact the final cost of mirabegron. Some pharmacies may offer lower prices through loyalty programs or by carrying a wider range of generic options. Insurance coverage can also significantly reduce out-of-pocket expenses, with copays varying based on the specific plan.
Are there any assistance programs for mirabegron costs?
Patient assistance programs, often sponsored by pharmaceutical manufacturers or independent foundations, may be available to help individuals who struggle to afford their medications. Eligibility for these programs typically depends on income and insurance status. Additionally, prescription discount cards can sometimes lower the cost for those without insurance or with high deductibles.
When does the patent for mirabegron expire?
The patent expiration dates for drugs like mirabegron are crucial for determining when generic versions can enter the market, thereby potentially lowering costs. Information on patent exclusivity and expiry can be found through resources that track pharmaceutical intellectual property.
How does mirabegron work to treat overactive bladder?
Mirabegron is a beta-3 adrenergic agonist. It works by relaxing the detrusor muscle in the bladder wall, which increases bladder capacity and reduces the involuntary contractions that cause symptoms of overactive bladder, such as urinary urgency, frequency, and urge incontinence [2].
What are the common side effects of mirabegron?
Common side effects associated with mirabegron use can include high blood pressure, urinary tract infections, headache, and constipation. Less frequently reported side effects may occur, and patients are encouraged to discuss any concerns with their healthcare provider.
How does mirabegron compare to other overactive bladder medications?
Mirabegron belongs to a different class of drugs than anticholinergics, which are a common first-line treatment for overactive bladder. While anticholinergics work by blocking acetylcholine to relax bladder muscles, mirabegron targets beta-3 adrenergic receptors. This difference in mechanism can lead to a distinct side effect profile, with mirabegron generally not causing the dry mouth or constipation often associated with anticholinergics.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.drugbank.ca/drugs/mirabegron